menu search

Cenovus energy, cnq shares higher on 3q results

Canadian Natural Resources Ltd (CNQ) on Thursday posted third-quarter adjusted earnings per share (EPS) that exceeded analysts' expectations on record...

November 2, 2023, 3:18 pm

Cenovus energy declares cad 0.14 dividend

Cenovus Energy (NYSE:CVE) declares CAD 0.14/share quarterly dividend, in line with previous. Payable De...

November 2, 2023, 12:44 pm

Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition

BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a c...

November 2, 2023, 9:15 am

Cenovus energy's quarterly profit rises as production climbs

Canadian oil and gas firm Cenovus Energy's quarterly profit rose on Thursday, helped by strong demand f...

November 2, 2023, 6:21 am

Corvus pharmaceuticals announces publication of preclinical data demonstrating potential of itk inhibition with soquelitinib as a novel approach to t cell-mediated inflammatory and immune diseases

Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides rationale for development in a range of additional Th...

November 1, 2023, 11:31 pm

Will cenovus (cve) beat estimates again in its next earnings report?

Cenovus (CVE) has an impressive earnings surprise history and currently possesses the right combination...

October 24, 2023, 1:32 pm

Harland & wolff spikes 15% after winning large oil vessel contract with cenovus

Shares in Harland & Wolff Group (AIM:HARL) were winched up 15% to 13p after the Belfast shipbuilder said it has won a £61 million contract to upgra...

October 20, 2023, 3:16 am

Synovus (snv) q3 earnings miss estimates, provisions rise

Higher provisions and expenses and a fall in NII hurt Synovus' (SNV) Q3 earnings. However, the rise in ...

October 19, 2023, 2:17 pm

Credit quality has been manageable and within our expectations, says synovus ceo kevin blair

Synovus CEO Kevin Blair joins 'Squawk on the Street' to discuss the credit quality Syno...

October 19, 2023, 1:10 pm

Compared to estimates, synovus (snv) q3 earnings: a look at key metrics

While the top- and bottom-line numbers for Synovus (SNV) give a sense of how the business performed in ...

October 18, 2023, 9:02 pm

Synovus financial (snv) lags q3 earnings estimates

Synovus Financial (SNV) came out with quarterly earnings of $0.84 per share, missing the Zacks Consensu...

October 18, 2023, 8:17 pm

Tg therapeutics: things are stacking up against briumvi

TG Therapeutics, Inc. stock has declined by 75% since its approval highs, with little hope of recovery. The company's fortunes have been tied to its e...

October 16, 2023, 4:47 pm

Cenovus energy: preferred shares could yield 8-12% upon reset

Cenovus Energy is a large integrated oil and gas producer in Canada with strong financial results and h...

October 14, 2023, 11:40 am

Here's why hold strategy is apt for cenovus (cve) stock now

Cenovus (CVE) remains dedicated to debt reduction through free cash flow generation and asset divestmen...

October 12, 2023, 9:46 am

Hologic (holx) to elevate ob-gyn training with new partnerships

Hologic's (HOLX) collaboration with AAGL and Inovus Medical is likely to optimize OB-GYN training for m...

October 12, 2023, 9:46 am

Alnylam: fda rejection of onpattro for attr-cm is a setback, but a manageable one

Despite a positive panel recommendation, the FDA rejected the Alnylam Pharmaceuticals, Inc. application to market Onpattro for ATTR-CM, citing a lack ...

October 10, 2023, 6:08 pm

Avus: active factor-based fund with short-term outperformance

Avantis US Equity ETF is an active factor-based ETF with a focus on lower-priced, higher-profitability stocks. A...

October 9, 2023, 11:46 pm

Cenovus energy inc: not getting a lot of value here

Cenovus Energy's dividend yield has fallen since 2014 and is now nearing a 2% yield. The company's ther...

October 5, 2023, 7:04 pm

Tg therapeutics: racing against time while their differentiators are still relevant

TG Therapeutics has transitioned from a developer of oncology drugs to a commercial-stage neurology company with the approval of its multiple sclerosi...

October 3, 2023, 2:26 pm

Synovus financial (snv) divests globalt to its leadership team

Synovus Financial (SNV) has wrapped up the deal to sell GLOBALT back to its leadership team....

October 3, 2023, 2:17 pm


Search within

Pages Search Results: